Tolfenpro gives producers new insecticide option to help address rotation and resistance



Bayer Bayer HealthCare Animal Health announces Tolfenpro™ Insecticide Ear Tag, an ear tag option with a new active ingredient to help producers control horn flies and face flies in beef cattle, non-lactating dairy cattle and lactating dairy cattle.

"Both horn flies and face flies can be a big problem for producers, potentially spreading disease and reducing weight gain," says Bruce Brinkmeyer, product manager for livestock insecticides at Bayer. "Tolfenpro will give producers a new option in fighting these pests, including those that have become pyrethroid- and organophosphate-resistant."

Tolfenpro utilizes a new active ingredient, Tolfenpyrad, in the pyrazole chemical class. It has a mode of action as a mitochondrial electron transport inhibitor, meaning that it prevents an insect's cells from producing the energy needed to function and live.

"Having a product with a new active ingredient and mode of action for ear tags will be helpful for producers who have seen or are worried about resistance," says Dr. Larry Hawkins, DVM, senior technical services veterinarian at Bayer. "It's important to rotate not just between active ingredients but also modes of action for an effective rotation strategy, and Tolfenpro fits well in a rotation program using pyrethroid, organophosphate or avermectin ear tags because it has a different mode of action."

Visit www.BayerLivestock.com for more information.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 20,0 billion (2014), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 60,700 employees (Dec. 31, 2014) and is represented in more than
100 countries.

Find more information at www.BayerLivestock.com
Follow us on Facebook: https://www.facebook.com/Bayer4Animals

Follow us on Twitter: https://twitter.com/Bayer4AnimalsUS
Return to Industry Buzz.

11.8.2015